The Glimepiride Market is gaining significant momentum globally, driven by the rising incidence of type 2 diabetes and the growing emphasis on cost-effective oral antidiabetic drugs. With an increasing number of patients seeking efficient, once-daily sulfonylureas, glimepiride has become a widely prescribed treatment, positioning the market for continued expansion throughout the forecast...